Connecticut 2020 Regular Session

Connecticut Senate Bill SB00328

Introduced
2/27/20  
Introduced
2/27/20  
Refer
2/27/20  
Refer
2/27/20  
Report Pass
3/10/20  

Caption

An Act Concerning Health Care Cost Growth Benchmarks, Canadian Drug Reimportation, Stop-loss Insurance And Reinsurance.

Impact

If passed, SB00328 would change the landscape of health care regulations in Connecticut significantly. Particularly, the establishment of health care cost growth benchmarks is anticipated to create a framework for monitoring and controlling cost increments in health care expenditures. Additionally, the bill facilitates the importation of safe prescription medications from Canada, which proponents argue can lead to lower prices for consumers and improve access to essential drugs. The implications on local pharmacies and wholesalers could be significant, as they would need to navigate new regulations regarding drug sourcing and distribution.

Summary

SB00328 aims to tackle health care costs by establishing benchmarks for health care cost growth in Connecticut while promoting Canadian prescription drug reimportation. The bill mandates the creation of an Office of Health Strategy within the Department of Public Health responsible for implementing a comprehensive health care vision. This includes setting annual growth benchmarks for health care expenses, targeting significant reductions in costs across the board. The bill's objective is to enhance transparency and efficiencies in health care spending, ultimately benefiting consumers by aiming for better health outcomes and reduced costs over time.

Contention

The bill has garnered mixed responses. Supporters express that the Canadian drug reimportation aspect is particularly critical to lowering prescription drug costs, but there are concerns from some stakeholders about the potential risks associated with foreign drugs and the impact on local pharmaceutical suppliers. Additionally, the parameters for monitoring and adherence to cost growth benchmarks may be viewed as burdensome by some health care providers. The discourse also highlights a gap between the intended goals of the bill and the realities of implementation, illustrating a common concern in health care legislative efforts.

Companion Bills

No companion bills found.

Similar Bills

CT HB05018

An Act Concerning Health Care Cost Growth In Connecticut.

CT SB01006

An Act Concerning Health Care Costs, The Connecticut Health Insurance Exchange And Health Equity.

CT SB00844

An Act Concerning The Insurance Department's Recommendations Regarding Value-added Products And Services And Prohibited Insurance Practices.

CT SB00008

An Act Concerning Drug Affordability.

CT HB05054

An Act Addressing Health Care Affordability.

CT HB05042

An Act Concerning Health Care Cost Growth.

CT HB06687

An Act Concerning Medical Assistance For Children And Adults Without Health Care Coverage.

CT SB01116

An Act Concerning A State-operated Reinsurance Program And Health Care Cost Growth.